Astrana Health, Inc. (NASDAQ:ASTH) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Astrana Health, Inc. (NASDAQ:ASTH) has received a consensus recommendation of “Moderate Buy” from the eleven research firms that are currently covering the firm, Marketbeat reports. Two analysts have rated the stock with a sell rating, one has given a hold rating and eight have issued a buy rating on the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $41.3333.

Several equities research analysts have recently weighed in on ASTH shares. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Astrana Health in a research report on Monday, December 29th. Jefferies Financial Group reissued a “buy” rating on shares of Astrana Health in a research note on Tuesday, November 25th. Needham & Company LLC assumed coverage on Astrana Health in a research report on Friday, December 12th. They set a “buy” rating and a $28.00 target price on the stock. TD Cowen cut their price target on Astrana Health from $40.00 to $35.00 and set a “buy” rating on the stock in a report on Monday, November 10th. Finally, BTIG Research decreased their price objective on Astrana Health from $50.00 to $45.00 and set a “buy” rating for the company in a research note on Friday, November 7th.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of ASTH. GAMMA Investing LLC raised its stake in shares of Astrana Health by 144.7% during the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock worth $37,000 after acquiring an additional 871 shares in the last quarter. Covestor Ltd grew its holdings in Astrana Health by 210.6% in the third quarter. Covestor Ltd now owns 3,233 shares of the company’s stock worth $92,000 after purchasing an additional 2,192 shares during the last quarter. Tower Research Capital LLC TRC increased its position in shares of Astrana Health by 323.3% during the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after purchasing an additional 3,517 shares in the last quarter. State of Wyoming acquired a new position in shares of Astrana Health during the second quarter worth $132,000. Finally, Citizens Financial Group Inc. RI acquired a new stake in shares of Astrana Health in the 3rd quarter worth $204,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Astrana Health Price Performance

ASTH opened at $28.43 on Tuesday. The company has a market capitalization of $1.60 billion, a price-to-earnings ratio of 149.64, a PEG ratio of 0.71 and a beta of 0.87. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.27. Astrana Health has a 12-month low of $20.12 and a 12-month high of $39.97. The business’s fifty day simple moving average is $24.44 and its 200-day simple moving average is $26.78.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings data on Wednesday, January 10th. The company reported $0.50 earnings per share for the quarter. Astrana Health had a net margin of 0.33% and a return on equity of 1.26%. The company had revenue of $317.00 million during the quarter. On average, equities research analysts anticipate that Astrana Health will post 1.15 earnings per share for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.